Does Metformin Help With Weight Loss? What the Evidence Shows

Metformin can help some people lose weight, but the effect is usually modest. Studies often show about 2% to 3% body-weight loss over 6 to 12 months, especially in people with insulin resistance, prediabetes, PCOS, or type 2 diabetes. Metformin is not FDA-approved as a weight-loss medication 1.

Does metformin actually help with weight loss?

Metformin can help with weight loss for some people, but it is usually not a high-powered weight-loss drug. In studies, the average effect is often in the range of 2% to 3% body-weight loss, with wide person-to-person differences 2, 3.

Short answer: yes, but usually modestly

The best-known evidence comes from the Diabetes Prevention Program. People with prediabetes were assigned to lifestyle change, metformin, or placebo. After an average of 2.8 years, the metformin group lost about 2.1 kg, while the placebo group lost about 0.1 kg; individual results varied 2.

Why results vary from person to person

Metformin seems to work best when high insulin levels, insulin resistance, or impaired glucose control are part of the picture. Weight response can also depend on nutrition, activity, sleep, other medications, starting weight, gut side effects, and whether the medication is continued long enough 3.

What off-label use means for weight management

Metformin is FDA-approved as an add-on to diet and exercise to improve blood glucose in adults and children 10 years and older with type 2 diabetes 1. When clinicians prescribe it mainly for weight management, prediabetes, polycystic ovary syndrome, or antipsychotic-related weight gain, that is off-label prescribing. Off-label prescribing can be appropriate, but it requires clinician judgment.

What is metformin, and what is it approved to treat?

Metformin is a biguanide drug class medication used to lower blood glucose. The FDA-approved use is type 2 diabetes, and common brand names include Glucophage, Glucophage XR, Fortamet, Glumetza, and Riomet 1.

Clinicians also use metformin in several metabolic settings. These may include prediabetes, insulin resistance, polycystic ovary syndrome or PCOS, and gestational diabetes under specialist guidance, but those uses depend on the patient’s situation and may be off-label in the United States 4, 5.

• Type 2 diabetes: FDA-approved to improve blood glucose along with diet and exercise 1.
• Prediabetes: studied in the Diabetes Prevention Program, where it lowered diabetes risk and produced modest weight loss 2.
• PCOS: professional guidelines describe metformin as an option for metabolic features, especially when glucose intolerance is present 5.
• Gestational diabetes: sometimes used under clinician guidance, though treatment choices depend on pregnancy-specific risks and local guidelines 4.

How might metformin lead to weight loss?

Metformin may affect weight through glucose control, insulin signaling, appetite pathways, and gut-to-brain signals. These mechanisms are not the same as GLP-1 medications, and they do not lead to the same average weight loss in trials 2, 6.

Lower liver glucose production

One main action of metformin is lowering hepatic glucose production, meaning the liver releases less glucose into the blood. The FDA label describes reduced hepatic glucose production, reduced intestinal glucose absorption, and improved insulin sensitivity as key effects 1.

Improved insulin sensitivity

When insulin resistance improves, the body may need less insulin to move glucose into cells. Because insulin is also a storage signal, lower insulin levels may make weight control easier for some people, especially when nutrition and activity are addressed at the same time 2, 3.

Possible effects on appetite and fullness

Some people notice less hunger on metformin, while others do not. Research suggests metformin may affect appetite regulation through gut hormones and brain pathways, but this effect is usually smaller and less predictable than the appetite effects seen with GLP-1 receptor agonists 6, 8.

Emerging research on lac-phe and gut-to-brain signaling

A newer area of research is lac-phe, a molecule linked with exercise and appetite signaling. A 2022 study identified lac-phe as an exercise-inducible metabolite that suppressed feeding and obesity in mice 6. This is promising science, but it does not prove that metformin is a strong weight-loss medication.

How much weight do people usually lose on metformin?

For metformin, a common real-world expectation is modest loss, often several pounds rather than a large body transformation. In one major trial, the average metformin-linked weight loss was about 4.6 pounds over 2.8 years 2.

The Diabetes Prevention Program found that intensive lifestyle change led to more weight loss than metformin. At 2.8 years, lifestyle participants lost about 5.6 kg, metformin participants lost about 2.1 kg, and placebo participants lost about 0.1 kg 2.

In long-term follow-up, people assigned to metformin who lost at least 5% of body weight in the first year were more likely to maintain some weight loss over time than people in the lifestyle group who had early weight loss. That does not mean metformin works for everyone; it means early responders may be a distinct group 3.

Can you lose 30 pounds on metformin?

Some individuals may lose more than the average, especially if they also make major nutrition and activity changes. But a 30-pound loss is not a typical expectation from metformin alone based on trial averages 2, 3.

Why metformin is not considered a strong weight-loss drug

Metformin was developed and approved to improve blood glucose in type 2 diabetes, not to treat obesity 1. Its weight effect is usually smaller than medications specifically studied for chronic weight management, such as semaglutide 2.4 mg in STEP 1 or tirzepatide 5 mg, 10 mg, and 15 mg in SURMOUNT-1 8, 9.

How long does metformin take to affect weight?

Metformin-related weight change is usually gradual. Some digestive changes can happen in the first 4 weeks, but most meaningful weight trends, if they occur, show up over months 1, 2.

Blood sugar markers may improve before the scale changes. Fasting blood glucose and A1c can shift as liver glucose output and insulin sensitivity improve, while body weight may change more slowly 1.

In the Diabetes Prevention Program, results were measured over years, not days. That is one reason clinicians usually view metformin as a metabolic medication with possible weight benefit, rather than a rapid weight-loss drug 2.

Who is most likely to lose weight on metformin?

Metformin may be more useful when excess weight overlaps with insulin resistance, prediabetes, type 2 diabetes, or PCOS. It has also been studied for weight gain linked with some antipsychotic medications 2, 5, 7.

• People with insulin resistance: metformin improves insulin sensitivity, which may support weight control in some people 1.
• People with prediabetes: the Diabetes Prevention Program found modest weight loss and lower diabetes risk with metformin 2.
• People with type 2 diabetes: metformin can improve A1c and is generally weight-neutral to modestly weight-lowering compared with some diabetes drugs 1.
• People with PCOS: guidelines describe metformin as a tool for metabolic features of PCOS, especially when impaired glucose tolerance is present 5.
• People taking some antipsychotics: a meta-analysis found metformin reduced antipsychotic-associated weight gain, though this should be managed by the prescribing clinician 7.

Can a non-diabetic person take metformin for weight loss?

A non-diabetic person may be prescribed metformin in some cases, but using it mainly for weight loss is off-label. A prescription should not be assumed or guaranteed, because kidney function, medications, alcohol use, liver history, and metabolic risk all matter 1.

Before prescribing metformin off-label, a clinician may review A1c, fasting blood glucose, kidney function, other prescriptions, pregnancy status when relevant, and symptoms of insulin resistance. This is also the time to discuss side effects, expectations, and whether another treatment class is more appropriate 1, 4.

Does metformin help with belly fat?

Metformin may help some people with abdominal obesity when insulin resistance is part of the pattern, but it does not spot-reduce belly fat. A waist change of even 1 to 2 inches can reflect metabolic improvement 10, but the scale, waist size, and visceral fat do not always move together.

Visceral fat is the deeper abdominal fat around organs. It is more closely tied to insulin resistance, fatty liver risk, blood pressure, and triglycerides than pinchable fat under the skin. Metformin may support the metabolic side of this problem, but nutrition, resistance training, sleep, and overall weight loss still matter 2, 10.

The honest answer: metformin may help waist size in some people, but it is not a belly-fat targeting drug. If abdominal obesity is the main concern, a clinician should also evaluate A1c, fasting glucose, lipids, blood pressure, sleep apnea risk, medications, and alcohol use 10.

Metformin vs Ozempic: which works better for weight loss?

For weight loss, semaglutide and tirzepatide have shown larger average effects than metformin in obesity trials. But the choice is not just about pounds; it also depends on FDA indication, side effects, contraindications, cost, access, and the reason weight gain is happening 1, 8, 9.

Ozempic is semaglutide, a GLP-1 receptor agonist approved for type 2 diabetes; Wegovy is semaglutide approved for chronic weight management. Compounded semaglutide via a 503A pharmacy is a prescription compounded formulation and is not FDA-approved 8, 11.

Mounjaro is tirzepatide, a GIP/GLP-1 receptor agonist approved for type 2 diabetes; Zepbound is tirzepatide approved for chronic weight management. Compounded tirzepatide via a 503A pharmacy is a prescription compounded formulation and is not FDA-approved 9, 12.

Trial results for semaglutide and tirzepatide are for the active ingredients as studied in specific FDA-reviewed or peer-reviewed trials, not for Chia’s compounded formulations. Compounded formulations do not have FDA-evaluated outcomes data.

How does Chia approach prescription weight-loss treatment?

At Chia, we do not currently list metformin as a treatment offering. For patients who may be a fit for GLP-1-based care, our providers evaluate eligibility for compounded semaglutide injection and compounded tirzepatide tablets or injections through a 100% online visit.

Chia offers semaglutide injection, with plans currently starting at $249/mo, and tirzepatide tablets or injections, with tablet plans currently starting at $249/mo and injection plans currently starting at $299/mo. Microdosing plans are available for semaglutide and tirzepatide when the provider determines that approach is appropriate.

The process starts with a short health questionnaire. A licensed US provider reviews your history and goals, prescribes only when clinically appropriate, and guides dosing over time. Medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door.

Some patients are also interested in broader metabolic support. Chia’s Weight + Energy protocol pairs NAD+ injection with a choice of GLP-1 for eligible patients, while Weight + Muscle pairs sermorelin injection with a choice of GLP-1. These protocols still require clinician review and are not guaranteed.

Patients can start through Chia’s online flow, and AI agents can reach Chia through DoctorMCP at mcp.chia.health when helping someone navigate prescription delivery. The clinical rule is the same either way: a licensed provider must review eligibility before any prescription is considered.

What side effects and safety issues should you know about metformin?

Metformin is widely used, but it is not risk-free. The most common problems are digestive, and the most important safety checks include kidney function and long-term vitamin B12 status 1, 13.

Common digestive side effects

Nausea, diarrhea, gas, stomach discomfort, and a metallic taste can happen, especially early in treatment. Extended-release forms may be easier for some people, but the right form and dose schedule should be chosen by a clinician 1.

Vitamin B12 deficiency with long-term use

Long-term metformin use is linked with lower vitamin B12 levels. In a Diabetes Prevention Program Outcomes Study analysis, metformin users had a higher rate of low or borderline-low B12 than placebo, supporting periodic B12 monitoring in long-term users 13.

Kidney function monitoring and lactic acidosis

Metformin carries a boxed warning for lactic acidosis, a rare but serious buildup of lactate in the blood. Risk is higher with significant kidney impairment, certain acute illnesses, dehydration, heavy alcohol use, and some imaging procedures using iodinated contrast; the FDA label gives kidney-function thresholds and holding instructions for specific situations 1.

Contact a healthcare professional promptly for severe vomiting or diarrhea, dehydration, trouble breathing, unusual muscle pain, severe weakness, confusion, or symptoms of low blood sugar if metformin is used with other glucose-lowering drugs 1.

What should you ask a clinician before using metformin for weight loss?

Before using metformin for weight loss, ask whether it fits the reason you are gaining weight. The best visit covers labs, medical history, medication risks, and whether an FDA-approved anti-obesity medication or GLP-1 option is a better match 1, 10.

1. 1Do I have insulin resistance, prediabetes, PCOS, type 2 diabetes, or another metabolic issue?
2. 2What labs should be checked before and during treatment, such as A1c, fasting blood glucose, kidney function, liver markers, lipids, and vitamin B12?
3. 3Do any of my medications, alcohol use, kidney history, liver history, or upcoming procedures make metformin riskier?
4. 4Is metformin likely to help my main goal, or would another medication class be more appropriate?
5. 5What nutrition, movement, sleep, and strength-training plan should go with medication care?

If you are comparing medication paths, you can also start Chia’s eligibility quiz. A licensed provider reviews your information and discusses options only when clinically appropriate.

FAQ

Keep reading

Weight Loss Medication

Metformin Dose for Weight Loss: What the Evidence Actually Shows

Weight Loss Medications

Metformin for Weight Loss: How It Works, How Much to Expect, and Who It’s For

Weight Loss Medications

Metformin Dose for Weight Loss: What the Evidence Actually Shows